---
title: "Zacks Research Brokers Reduce Earnings Estimates for.B."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295216746.md"
description: "Zacks Research lowered.B. Corp's Q3 2026 EPS estimate to $0.43 from $0.44. Other brokerages maintain mixed ratings, with a consensus 'Moderate Buy' and average target price of $20.70. FNB recently declared a $0.13 quarterly dividend. Insider Gary L. Guerrieri sold shares, while institutions like Goldman Sachs and Rhino Investment Partners increased their stakes in the first quarter."
datetime: "2026-08-07T10:13:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295216746.md)
  - [en](https://longbridge.com/en/news/295216746.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295216746.md)
generator: "portal-rs"
---

# Zacks Research Brokers Reduce Earnings Estimates for.B.

F.N.B. Corporation (NYSE:FNB - Free Report) - Analysts at Zacks Research decreased their Q3 2026 earnings per share estimates for F.N.B. in a research report issued on Thursday, August 6th. Zacks Research analyst Team now expects that the bank will post earnings of $0.43 per share for the quarter, down from their previous forecast of $0.44. The consensus estimate for F.N.B.'s current full-year earnings is $1.69 per share. Zacks Research also issued estimates for F.N.B.'s FY2026 earnings at $1.69 EPS, Q1 2027 earnings at $0.43 EPS, Q2 2027 earnings at $0.46 EPS, Q4 2027 earnings at $0.51 EPS, FY2027 earnings at $1.90 EPS, Q1 2028 earnings at $0.52 EPS and Q2 2028 earnings at $0.55 EPS.

A number of other brokerages have also weighed in on FNB. Piper Sandler restated an "overweight" rating on shares of F.N.B. in a research report on Monday, July 20th. Keefe, Bruyette & Woods lifted their price target on shares of F.N.B. from $20.00 to $21.00 and gave the company an "outperform" rating in a report on Monday, April 20th. Wall Street Zen cut shares of F.N.B. from a "hold" rating to a "sell" rating in a research note on Tuesday, July 28th. Weiss Ratings reissued a "buy (b)" rating on shares of F.N.B. in a report on Tuesday, June 9th. Finally, Bank of America restated a "neutral" rating and set a $19.00 price objective (down from $20.00) on shares of F.N.B. in a research report on Monday, July 20th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, F.N.B. presently has a consensus rating of "Moderate Buy" and an average target price of $20.70.

**Get Our Latest Research Report on FNB**

## F.N.B. Trading Down 1.1%

Shares of FNB opened at $18.99 on Friday. The firm has a market cap of $6.76 billion, a P/E ratio of 11.30, a price-to-earnings-growth ratio of 1.22 and a beta of 0.85. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.92 and a quick ratio of 0.91. F.N.B. has a 1 year low of $14.45 and a 1 year high of $19.59. The company has a 50 day simple moving average of $18.65 and a two-hundred day simple moving average of $17.83. 

F.N.B. (NYSE:FNB - Get Free Report) last issued its earnings results on Friday, July 17th. The bank reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. F.N.B. had a return on equity of 9.10% and a net margin of 22.29%.The company had revenue of $463.00 million for the quarter, compared to the consensus estimate of $467.13 million. During the same quarter last year, the company earned $0.36 EPS. 

## F.N.B. Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a $0.13 dividend. This represents a $0.52 annualized dividend and a yield of 2.7%. The ex-dividend date is Tuesday, September 1st. F.N.B.'s payout ratio is currently 30.95%. 

## Insiders Place Their Bets

In related news, insider Gary L. Guerrieri sold 19,000 shares of the company's stock in a transaction on Friday, June 12th. The shares were sold at an average price of $18.53, for a total transaction of $352,070.00. Following the sale, the insider owned 298,097 shares of the company's stock, valued at $5,523,737.41. This represents a 5.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.50% of the company's stock. 

## Institutional Trading of F.N.B.

A number of large investors have recently made changes to their positions in FNB. Goldman Sachs Group Inc. lifted its holdings in shares of F.N.B. by 77.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,513,248 shares of the bank's stock valued at $20,353,000 after acquiring an additional 660,387 shares during the last quarter. Rhino Investment Partners Inc increased its stake in F.N.B. by 47.8% during the first quarter. Rhino Investment Partners Inc now owns 1,207,418 shares of the bank's stock worth $20,188,000 after acquiring an additional 390,526 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in F.N.B. by 5.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,049,241 shares of the bank's stock valued at $14,112,000 after purchasing an additional 58,672 shares during the period. SG Americas Securities LLC lifted its stake in shares of F.N.B. by 585.2% in the 1st quarter. SG Americas Securities LLC now owns 358,244 shares of the bank's stock valued at $5,990,000 after purchasing an additional 305,961 shares during the last quarter. Finally, Royal Bank of Canada boosted its holdings in shares of F.N.B. by 11.6% in the 1st quarter. Royal Bank of Canada now owns 274,466 shares of the bank's stock worth $3,692,000 after purchasing an additional 28,570 shares during the period. 79.25% of the stock is currently owned by institutional investors. 

## F.N.B. Company Profile

(Get Free Report)

F.N.B. Corporation is a bank holding company headquartered in Pittsburgh, Pennsylvania. Through its principal subsidiary, FNB Bank, the company provides a broad range of commercial and consumer financial services. Founded in 1864 as the First National Bank of Pennsylvania, F.N.B. has grown through both organic expansion and strategic acquisitions to become a regional banking franchise. 

The company's main business activities include traditional deposit-taking and lending services, such as checking and savings accounts, mortgages, home equity lines of credit, and consumer and commercial loans.

## Read More

-   Five stocks we like better than F.N.B.
-   Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling
-   4 Oil and Gas ETF Plays as Prices Stay Sky-High
-   What Tesla Stands to Lose If It Walks Away From China
-   Disney Sets Up for a Magical Year in 2027

*This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.*

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source
## Should You Invest $1,000 in F.N.B. Right Now?

Before you consider F.N.B., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and F.N.B. wasn't on the list.

While F.N.B. currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

### Related Stocks

- [FNB.US](https://longbridge.com/en/quote/FNB.US.md)
- [B.US](https://longbridge.com/en/quote/B.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [GS-D.US](https://longbridge.com/en/quote/GS-D.US.md)
- [GS-C.US](https://longbridge.com/en/quote/GS-C.US.md)
- [GS-A.US](https://longbridge.com/en/quote/GS-A.US.md)
- [BU.US](https://longbridge.com/en/quote/BU.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Goldman Sachs lifts Aurubis voting rights to 12.37% from 11.79%](https://longbridge.com/en/news/296369399.md)
- [Goldman Sachs trims Gerresheimer voting rights to 18.01% from 18.62%](https://longbridge.com/en/news/296493196.md)
- [Goldman Sachs lifts K+S voting rights to 12.18% from 7.24%](https://longbridge.com/en/news/296186403.md)
- [Goldman Sachs voting rights in Hypoport slip to 4.95% from 5.09%](https://longbridge.com/en/news/296349944.md)
- [Lee Johnson Capital Management LLC Purchases Shares of 5,524 The Goldman Sachs Group, Inc. $GS](https://longbridge.com/en/news/296678209.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**